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1. INTRODUCTION 2. METHODS 
Synaptosomes have proved most useful in in- 
vestigating the biochemistry of the synapse [l]. A 
major limitation in the use of synaptosomes from 
mammalian brain is the heterogeneity of the pre- 
parations with respect o transmitter type. An abil- 
ity to discriminate between sub-populations of 
nerve-terminals would allow these sub-populations 
to be counted, and even separated in a manner that 
has been found possible for subclasses of lympho- 
cytes 121. Elimination of a sub-population would 
allow greater certainty in attributing specific pro- 
perties to a nerve-ending type (e.g., in studying 
pre-synaptic receptors [3]). 
Antisera to synaptosomes have been described 
which affect synaptosomal properties [4-81; how- 
ever, only a few studies have used antisera seeming- 
ly capable of selectively affecting sub-populations 
of synaptosomes 19, lo]. 
Here, an antiserum to a purified choline acetyl- 
transferase preparation, acting with complement, 
appeared to lyse cholinergic synaptosomes, while 
having no action on synaptosomes capable of 
taking up y-amino-butyric acid (GABA). 
+To whom all correspondence should be addressed 
Abbreviations: ChAT, choline acetyltransferase (EC 
2.3.1.6);DABA,2,4-di-amino-butyricacid;GABA,y-amino- 
butyric acid; LDH, lactate dehydrogenase (EC 1.1.1.27) 
Antiserum Lactate dehydrogenase Uptake 
An antiserum was prepared from the partially 
purified bovine enzyme (Sigma) by injection of an 
oil-in-water emulsion prepared using Freund’s 
complete adjuvant. The emulsion, containing - 1 mg 
protein, was injected intramuscularly into a 
Californian rabbit; 51 days after the initial immu- 
nization a further 100 pg protein was injected in- 
tradermally into a site on the back. Blood samples 
were taken before and at several intervals during 
the course of immunization. 
The presence in the serum of antibodies to the 
choline acetyltransferase (ChAT) preparation, was 
tested by double immunodiffusion [1 I]. Dilutions of. 
the antiserum were tested against a solution of the 
antigen in phosphate-buffered saline. 
Direct immunoprecipitation of ChAT activity 
from a rat brain soluble supematant fraction (11000 
xg/40 min, [ 121) was achieved using dilutions 
of the antiserum and Pansorbin (Gibco Labs.). Brief- 
ly, in 1 .O ml a total vol. dilutions of antiserum were 
incubated at room temperature for 1 h with the 
rat brain supernatant showing ChAT activity. An 
aliquot (50 ~1) of resuspended Staphylococcus A 
cells (Pansorbin) was introduced, and the incuba- 
tion allowed to continue at room temperature for a 
further 30 min. Staphylococcus A cells were remov- 
ed from the suspension by centrifugation in a 
bench ultracentrifuge for 5 min. The enzyme was 
assayed in the supernatant and the resuspended 
pellet using 0.4 mM [I-14C]acetyl coenzyme A 
(4 mCi/mmol, Amersham International) by the 
method in [ 131. 
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The sodium-dependent uptake of [3H]choline 
(15 Ci/mmol, Amersham International) into rat 
cerebrocortical synaptosomes [ 141 was measured 
at 0.0625-2 PM choline as in [16], using smaller 
volumes (500 ~1) in Eppendorf tubes, in triplicate. 
In some experiments the action of 1 PM hemi- 
cholinium on choline uptake was tested. This was 
present during the 5 min preincubation of the 
synaptosomes before the choline was added. 
Sodium-dependent uptake 4-amino-n-[2,3-3H]bu- 
tyric acid, at 0.125-4 PM, into synaptosomes was 
measured by the same method. In some experi- 
ments synaptosomes were preincubated with Krebs 
medium containing 100 PM 2,4-diamino-butyric 
acid (DABA) prior to the assay of GABA uptake. 
Uptake of GABA was also assayed in synaptosomes 
that had been lysed in 8 mM Tris-HCl (pH 8.1) 
(1 mg synaptosomal protein/ 10 ml) for 30 min at 
0-4°C. Synaptosomes were pelleted at 3000 xg 
and re-suspended in 0.32 M sucrose at 2 mg pro- 
tein/ml. Eadie-Hofstee plots of Yagainst I//S, were 
constructed to determine V,,, and &,-values. 
Straight lines were fitted to the data by linear re- 
gression. 
Lactate dehydrogenase (LDH) activity was 
measured as in [ 161. 
The actions of the antisera were tested by incu- 
bating cortical synaptosomes (400 pg protein/ml) in 
10 ml sodium-free Krebs’ Ringer phosphate which 
contained either antiserum (0.2 or 2.0 ml) plus 1 ml 
of guinea pig complement (Gibco Labs), or the 
antiserum alone, for 30 min at 37°C. After this 
incubation, the synaptosomes were deposited by 
centrifugation at 3000 x g. The supernatant was re- 
tained for LDH assay, and the pellets were first 
surface-washed with sodium-free Krebs’ Ringer 
before being resuspended in 0.32 M sucrose (2 mg 
synaptosomal protein/ml) for the assay of choline 
or GABA uptake, where 50 ~1 of this suspension was 
added to 500 ~1 final incubation vol. LDH activity 
in the pellets was measured after lysis produced by 
the addition of 8 mM Tris-HCl (pH 8.1) and 
freezing and thawing, twice. 
3. RESULTS AND DISCUSSION 
A dilution of 1: 16 of the antiserum with phos- 
phate-buffered saline produced a precipitate in the 
double immunodiffusion test against the partially 
purified ChAT preparation. The more sensitive 
48 
method of direct immunoprecipitation caused 100% 
precipitation of ChAT activity without loss of 
activity (769 2 96 pmol . 15 min -’ . mg rat brain 
protein -1, 6 separate prep) at a dilution of anti- 
serum of 1:5. Staphylococcus A cells incubated in 
the absence of antiserum were capable, however, of 
precipitating 20% of the enzyme activity. 
The results of table 1 show that the antiserum 
caused total suppression of the sodium-dependent 
uptake of choline at a dilution of 1:5 in the incuba- 
tion medium, provided complement was added. 
Sodium-independent uptake was unaffected, ac- 
counting for 25% of the total uptake at 0.5 PM 
choline (not shown). A dilution of antiserum of 1:50 
caused a halving of the V,,, without altering the 
Km, showing a dose-dependent relationship. Anti- 
serum alone at these dilutions caused an increase in 
K,, the 1:5 dilution producing a 2-fold change. 
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Fig. 1. Typical Eadie - Hofstee plots of sodium-depen- 
dent GABA uptake into control (m-0) and lysed 
(O-O) synaptosomes, and synaptosomes incubated with 
100 pM DABA (A-A). Data shown are the mean of 
triplicate determinations at each GABA concentration. 
Lines through the points were determined using linear 
regression analysis. 
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Table 1 
Effects of partially purified choline acetyltransferase antiserum on cerebrocortical synaptosomes 
prepared from rat 
Treatment 
Sodium-dependent 
choline uptake 
V mm Km 
Sodium-dependent 
GABA uptake 
V mm Km 
Lactate dehydrogenase 
activity (% release) 
Krebs medium 5525 0.54 f 0.05 
Pre-immune 
antiserum (1:5) 
+ complement 5927 0.52 + 0.06 
Anti-serum 
(1:50) 
+ complement 2725 0.55 + 0.04 
Antiserum ( 1: 5) 
+ complement Not meas. Not meas. 
Antiserum 
(1:50) 5624 0.58 + 0.05 
Antiserum ( 1: 5) 58+6 1.2 kO.09 
Complement 52?5 0.53 f 0.05 
78O-c69 
760 + 92 
Not est. 
680 f 80 
Not est. 
Not est. 
772 k 80 
4.9 + 0.5 4- 6% 
5.1 kO.6 5- 8% 
Not est. 16-208 
5.420.7 30-34% 
Not est. 5- 8% 
Not est. 5- 7% 
5.220.5 4- 8% 
Values given for uptake are mean + SD from 7 separate synaptosome preparations. Total lactate 
dehydrogenase activity in synaptosomes was 1.28 f 0.11 pmol . mg synaptosomal protein -I. 
mint . V,,, is given in units of pmol . mg synaptosomal protein -r .2 min -t . K,,, is given in 
units of PM. 
This effect was similar to the action of 0.1 PM he- 
micholinium, which is known to block uptake in a 
competitive manner (not shown). Pre-immune se- 
rum and complement, and complement alone, 
however, were without effect. 
The sodium-dependent uptake of GABA was not 
changed by the antiserum, with respect to either 
V max or Km, though DABA (100 PM) could sub- 
stantially reduce its uptake (92% reduction of con- 
trol at 1 nM GABA, @.I). Sodium-independent 
uptake was similarly unaffected by the antiserum, 
accounting for - 10% of the uptake at 1 PM GABA. 
Measurement of LDH showed that this soluble 
enzyme was released into the incubation medium to 
the extent of 30-34% by the antiserum at the 1:5 
dilution, and by 16-20% at the I:50 dilution, pro- 
vided complement was present. Neither comple- 
ment alone, nor antiserum alone caused any release 
of LDH control levels. 
The results indicate that the antiserum contains 
antibodies able to lyse - 1/3rd of cortical synapto- 
somes, whilst totally preventing sodium-dependent 
choline uptake. The lack of action on GABA uptake 
indicates a degree of specificity .in the lysis, and 
suggests it may be confined to cholinergic terminals. 
GABA uptake was reduced to low levels by 
hypotonic lysis. Uptake no longer conformed to 
Michaelis-Menten kinetics (fig.1; r = -0.51, y = 
130-2.57x). 
If the antiserum and complement has caused 
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similar membrane lesions on GABA-terminals, 
GABA uptake should have been affected. 
The immunoprecipitation tests are consistent 
with the presence of antibodies to ChAT. If inter- 
action between ChAT antibodies and complement 
is the mechanism leading to synaptosomal lysis, 
then ChAT is presumably present and accessible in 
the outer surface membrane of cholinergic syn- 
aptosomes. Should ChAT antibodies and comple- 
ment gain acces to the inner surface of the mem- 
brane, then lysis could result, but this seems a less 
tenable explanation. 
In [ 10,171 similar complement-mediated lysis 
(i.e., LDH release) of guinea-pig cortical synapto- 
somes was reported in the presence of a polyclonal 
antiserum to the nerve-terminals (T-sacs) of Torpe- 
do electric organ, but have not identified the specific 
antigens responsible. In [8] antisera to whole syn- 
aptosomes in the presence of complement cause 
increased permeability to K+ and Ca2+ but not to 
proteins such as LDH. The differences in these re- 
sults may be explained by varying treatment pro- 
cedures, and by the nature and distribution of the 
antigens involved. 
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